title: Cell therapy companies make strong progress from October 2012 to March 2013 amid mixed stock market sentiment.
abstract: During Q4 2012 and Q1 2013, the cell therapy industry made strong progress in translation and commercialization. Continued development of the companies included in a dedicated stock market index suggests emergence of this industry as a distinct healthcare sector.
authors.affiliation: Advanced Centre for Biochemical Engineering, University College London, Gower Street, London, WC1E 6BT, UK. chris.mason@ucl.ac.uk
authors.forename: Chris
authors.initials: C
authors.lastname: Mason
authors.forename: Julian
authors.initials: J
authors.lastname: Mason
authors.forename: Emily J
authors.initials: EJ
authors.lastname: Culme-Seymour
authors.forename: Gregory A
authors.initials: GA
authors.lastname: Bonfiglio
authors.forename: Brock C
authors.initials: BC
authors.lastname: Reeve
mesh_terms: D006801:Humans; D007449:Investments / Q000191:economics*; D057905:Stem Cell Research / Q000191:economics*; D033581:Stem Cell Transplantation / Q000191:economics*